SLA 0.00% $3.34 silk laser australia limited

key mates, page-54

  1. 4,056 Posts.
    lightbulb Created with Sketch. 953
    Crumbs, you take a pretty tough line on our scientific comrades there, Col8.

    My own view of those folk would be that, as clever as they undoubtedly are in their professional fields, they are - or were! - financial ingénues...and I'd certainly like to see them properly looked after!

    Practical considerations aside, it is something of a national disgrace to see them shonked by the dubious machinations of Australian institutions after so many years' hard work!!!

    The shameful irony of it, when we Aussies have p'raps generally felt so superior in our commercial morés to others in the world!

    Fair go, mate.


    A timely reminder from you, though, of the sheer fecundity of the research program developed by these people. Yes, indeed...good to recall the potential benefits of alternate (liposomal, water-soluble/intravenous) delivery systems for Ropren. Because you're quite right, a potential hundred-fold reduction in the required dose was once mooted!

    Roll on more news!!!

 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.